Full-Time
Posted on 10/4/2025
AI-powered procurement platform for life sciences
$100k - $130k/yr
Boston, MA, USA
Hybrid
Three days in-office per week required; must reside in the greater Boston area.
| , |
Labviva provides an AI-powered procurement platform for the life sciences sector. It runs a digital marketplace that connects researchers and procurement teams with a broad network of suppliers while integrating with enterprise systems like SAP Ariba, Oracle Procurement Cloud, and JAGGAER so organizations can keep existing contracts and pricing. AI powers advanced search and analyzes product attributes from scientific literature to help users compare products and find cost-saving options, and an automated inventory management system offers real-time stock visibility with AI forecasting and QR-based replenishment. The goal is to streamline life sciences purchasing, reduce costs, and improve lab operations by expanding access to suppliers and providing actionable analytics.
Company Size
51-200
Company Stage
Series B
Total Funding
$55M
Headquarters
Cambridge, Massachusetts
Founded
2017
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Hybrid Work Options
Paid Vacation
Parental Leave
Company Equity
TT Electronics announces new permanent CFO. By Michael Griffiths 10/04/2026 TT Electronics has announced the appointment of Ian Ashton as the group's new chief financial officer (CFO). Ashton, who will also become an executive director at TT, is currently the CFO of SIG, a role he has had since 2020. Prior to joining SIG, Ashton served as CFO at Low & Bonar until its acquisition by the Freudenberg Group, and before that he was CFO of Labviva, a US-based technology company. He has also served in several senior financial roles at Smith & Nephew. Ashton will join TT following the completion of his current notice period of up to a maximum of six months. He will succeed Richard Webb in the role, who has been TT's interim CFO since May last year. Webb will continue on an interim basis until Ashton joins TT, and will support an orderly handover. "I'm delighted to have been appointed CFO of TT," Ashton said. "The group has a huge amount of potential, with strong market positions and a clear strategy in place, and I am excited at what lies ahead. I greatly look forward to working alongside Eric and the rest of the management team to help deliver further operational and financial progress." TT's CEO, Eric Lakin, added: "Corporate Finance News is delighted to announce Ian's appointment as CFO. He brings a strong combination of financial expertise, operational insight and leadership experience, which will support the group in building on the positive progress achieved over the past 12 months in creating a clearer strategic direction and a stronger platform for growth. "I would like to thank Richard for his support, and I look forward to working with him to ensure a smooth transition. Ian is an excellent fit for TT and I'm excited about working closely with him."
Labviva announced the general availability of Harper Chemical (HarperChem), a new part of its cloud-based inventory management system (IMS).
Leading life sciences technology company to accelerate adoption of automated procurement and supplier diversity worldwideBOSTON and LONDON , May 15, 2025 (GLOBE NEWSWIRE) -- Tariffs, trade barriers, and fragmented regulatory environments are disrupting the global supply chain and threatening the life sciences industry worldwide. That’s why Labviva, the leading AI procurement platform for life sciences, today announced its entry into Europe, establishing an international headquarters in London, and appointing life sciences veteran Dr. Carlo Iannicola as general manager. As part of the announcement, the company plans to accelerate global adoption of AI-enabled supply chain procurement while delivering a vast pool of diversified suppliers to Europe’s life sciences community.Resolving a Fragmented Global Life Sciences Supply ChainMcKinsey reports that pharmaceutical procurement is inefficient and time-consuming, citing manual entries consume up to 30% of staff time, while life sciences suppliers struggle to digitize and integrate key data sources. It also recently identified augmented sourcing and realtime inventory optimization as powerful use cases capable of driving mass efficiencies in the sector. With the potential to reduce procurement management costs by up to 10% and increase productivity by up to 80%, AI in biopharmaceutical operations is a $7 billion annual business.The “Amazonification” of Supply Chain ProcurementLabviva instantly connects research organizations with 90% of all life sciences manufacturers in the U.S
Labviva, an AI procurement platform for life sciences, secured $25 million in Series B funding, totaling $55 million. Led by 53 Stations, with participation from Biospring Partners, B Capital Group, and Glasswing Ventures, the funds will accelerate product development, marketing, and global expansion. Jason Pritzker from 53 Stations joins Labviva's Board. Labviva aims to enhance supply chain transparency and efficiency in life sciences, supporting major pharmaceutical companies and research institutions.
Labviva secures $25M to accelerate product development and global expansion.